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Abstract
Objective: Pregnancy and postpartum iron status is of great public health importance,
yet few studies have examined predictors of haemoglobin (Hb) concentration during
this time. We identified predictors of Hb from 24 weeks’ gestation until delivery and
from 4 to 25 weeks postpartum.
Design: Blood was drawn as many as four times during care: at the initial visit, at 24–
29 weeks’ gestation, at delivery and postpartum. A longitudinal, multivariable linear
regression model was used to predict Hb concentration.
Setting: A public health clinic in Raleigh, North Carolina.
Subjects: n ¼ 520 women who participated in the Iron Supplementation Study.
Results: Hb concentration at the previous blood draw, short stature, non-Hispanic
white ethnicity/race, .12 years of education and smoking were positive predictors of
pregnancy and postpartum Hb concentrations. Iron supplement use was a positive
predictor, while inadequate weight gain and severe nausea/vomiting were negative
predictors of gestational Hb. A high infant birth weight and postpartum haemorrhage
were negative predictors of postpartum Hb. Pre-pregnancy body mass index had a
slight positive relationship with gestational Hb, but had a strong negative relationship
with postpartum Hb. The longitudinal model also confirmed the typical pattern of
gestational Hb concentration. As the number of weeks between the initial visit and the
24- to 29-week visit increased, Hb at 24–29 weeks’ gestation decreased. As gestational
age increased from 24 weeks until delivery, Hb concentration increased as well.
Conclusions: The predictors identified here could be used in clinical settings to target







Poor iron status, common among low-income pregnant
and postpartum women in the United States1–3, is
associated with reduced work capacity4, impaired
cognition5,6 and adverse birth outcomes7. Iron status is
the most important biological determinant of haemo-
globin (Hb) concentration among women of childbearing
age in the USA8. Therefore, iron intake, iron stores, iron
requirements and iron losses during and after pregnancy
are likely to predict Hb concentrations. Hb concen-
trations during and after pregnancy are also greatly
influenced by blood volume changes. Hb decreases by
nearly 20 g l21 during the first two trimesters of
pregnancy as a result of normal plasma volume
expansion9 – even with adequate iron supplemen-
tation10. Among supplemented women, Hb concentration
rises from approximately 24 weeks’ gestation to term10.
By 6 weeks postpartum, Hb concentration is expected to
return to first-trimester or pre-pregnancy levels11. Despite
the public health importance of poor iron status and the
vast changes to pregnancy and postpartum haematolo-
gical status, few studies have assessed predictors of Hb
concentration during this time12,13. Understanding
the relative importance of these factors in the prediction
of Hb concentration is important, because changes in
Hb concentration are used to monitor response to iron
interventions on both the individual14 and the
population level15. Our objective in the present study
was to identify predictors of Hb concentration from 24
weeks’ gestation until delivery and from 4 to 25 weeks
postpartum.
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Population and methods
Data came from the Iron Supplementation Study16, a
randomised, double-blinded, placebo-controlled clinical
trial of iron supplementation during pregnancy. The goal
of the study was to determine the effect of selective versus
universal iron supplementation during the first two
trimesters on third-trimester iron status. The study
recruited women initiating care at a public prenatal clinic
in Raleigh, NC that serves women of mostly low socio-
economic background. Women were approached in the
clinic waiting area at their first prenatal visit by a study
recruiter. Eligible women were those who were ,20
weeks’ gestation, carrying singletons, English-speaking,
and had no known blood disorders. Eight hundred and
sixty-seven women gave their informed, written consent.
Blood was drawn at recruitment and analysed for Hb
and serum ferritin (SF) concentrations, which were used to
randomise women into a supplementation group receiv-
ing a daily prenatal vitamin with 0, 30 or 60 mg of iron.
Supplementation began immediately and continued until
24 to 29 weeks’ gestation, when blood was drawn again
and analysed for Hb and SF concentrations. Compliance to
study supplements was measured indirectly through pill
counts, questionnaires and clinic pharmacy records (date
of dispensing and refill, dose of iron in each supplement).
At 24 to 29 weeks’ gestation active participation ended,
and women received the standard clinic protocol,
including prenatal vitamins containing 30 mg iron if not
anaemic and a higher-dose supplement if anaemic.
Women were followed through the rest of pregnancy
and into the early postpartum period, when clinic
pharmacy records were again examined to assess
supplement use during the remainder of pregnancy.
Data from medical records were abstracted to ascertain
information on reproductive history, pregnancy compli-
cations, health habits, Hb concentration before delivery
and at the postpartum visit, and infant feeding method.
The study was approved by the institutional review board.
For the 867 women randomised, Hb data were available
for as many as four blood draws (initial visit, 24–29 weeks’
gestation, before delivery and postpartum). We were
interested in predicting Hb concentrations at the latter
three visits for women who delivered a live birth. Of the
867 women randomised, 719 were known to deliver a live
infant, while the remainder had a known spontaneous
abortion, therapeutic abortion or foetal death (n ¼ 64), or
were lost to follow-up (n ¼ 84). Of the 719 known to
deliver a live birth, 520 (72%) had complete data on Hb
concentration and corresponding predictors for at least
one of the three aforementioned visits. About 57% of the
520 women had information at all three visits (n ¼ 296),
while almost all remaining women had data at one of the
three visits (42%; n ¼ 218). Missing data occurred because
in this transient, low-income population, many women
missed appointments, transferred to other clinics, moved,
delivered at other hospitals, or did not return for a
postpartum visit. All 520 women were included in our final
longitudinal model since it was built to accommodate such
missing data (discussed below). The 520 women used in
the analysis were similar to the 867 women randomised
with respect to age, ethnicity/race, education, parity,
marital status, gestational age at prenatal care entry, Hb
concentration at the initial visit, and SF concentration at
initial visit. Furthermore, among the 520 women in the
analysis, there were no meaningful differences with
respect to these maternal characteristics when comparing
the 296 women with data available for all three visits with
those 218 women contributing information from one visit.
Main outcome measures and predictors
Venous blood samples taken by the prenatal clinic staff
were routinely analysed for Hb concentration using a
HemoCue technique. Medical records were used to
ascertain Hb concentration no more than 7 days before
delivery and at the postpartum visit. SF concentration was
analysed using a radioimmunoassay technique by
LabCorp of America (Burlington, NC, USA).
Gestational age (GA) was based on a reliable, self-
reported estimate of last menstrual period (LMP) or an
ultrasound done early in pregnancy if LMP was unknown.
When both estimates were available and were within 14
days of one another, we used the LMP to estimate GA.
When the difference in estimates exceeded 14 days, we
used the ultrasound to estimate GA.
Cumulative dose of iron from supplements was
estimated using a combination of pill-count and pharmacy
data, as described previously17. Briefly, 31% of women
had complete pill-count and pharmacy data, whereas the
remaining 69% had pharmacy data only. Since pill-count
data were considered our ‘gold standard’, we estimated
percentage compliance (0–100%) using pill-count data for
the 31% of women with such data. For the remaining 69%,
clinic pharmacy records were used to estimate pill-count
data. Specifically, we first used linear regression to
quantify the association between pill-count and pharmacy
data among the 31% with both types of data. Then we used
simple regression imputation to impute pill-count data for
the remaining 69%.
For each study supplement or clinic supplement picked
up at the pharmacy, we calculated the therapeutic dose of
iron received as:
Amount of iron ðmg day21Þ in the prescribed
supplement £ number of days between
dispensing and refill £ percentage compliance:
We then summed these doses of iron to estimate the
cumulative dose of iron from the initial visit to the 24- to
29-week blood draw and from the 24- to 29-week blood
draw to delivery. Finally, we categorised cumulative dose
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of iron in each time period into four groups reflecting iron
intake relative to the 30 mg day21 dose that is rec-
ommended for non-anaemic pregnant women15. From the
start of prenatal care until 24–29 weeks’ gestation,
30 mg day21 corresponded to a cumulative dose of 2.0–
3.5 g since most women in our study had the opportunity
for 10–16 weeks of supplementation. Therefore, we
categorised women into one of four groups: 0 g, 0.1–1.9 g
(,prescribed), 2.0–3.5 g (prescribed) and .3.5 g
(.prescribed). For the remainder of pregnancy, most
women had the opportunity for 10–14 weeks of
supplementation, so the categories were 0 g, 0.1–1.9 g
(,prescribed), 2.0–3.0 g (prescribed) and .3.0 g
(.prescribed). Comparable data on postpartum iron
supplement use were unavailable.
Pre-pregnancy body mass index (BMI), calculated as
weight (in kg) divided by the square of height (in m), was
based on measured height and maternal report of pre-
pregnancy weight at the initial visit. Maternal weight was
measured at each prenatal visit. We calculated total weight
gain by subtracting pre-pregnancy weight from weight at
the last prenatal visit. To calculate each woman’s expected
gestational weight gain at 24–29 weeks and before
delivery, we used the Institute of Medicine’s (IOM) pre-
pregnancy BMI-specific weight-gain recommendations9 in
combination with GA at the weight measurement at or
before the blood draw. We used the following equation18:
Expected gestational weight gain
¼ recommended first-trimester total weight gain
þ ½ðGA at weight measurement at or before blood
draw 2 13 weeksÞ £ recommended rate of gain
in second and third trimestersÞ:
We then divided total weight gain by expected weight gain
and multiplied by 100 to calculate the percentage of
weight-gain recommendations met. Finally, in recognition
that the IOM recommended a range of total gestational
weight gain for each pre-pregnancy BMI group, we
classified the percentage of weight-gain recommendations
met as inadequate, adequate or excessive. For each BMI-
specific range, therefore, we divided the lower and upper
limits of recommended weight-gain range by expected
weight gain at 40 weeks’ gestation and multiplied by 100 to
calculate corresponding ranges of recommended percen-
tage of expected weight gain. We used these ranges as the
basis for categorising weight-gain adequacy: inadequate
(, lower cut-off of recommendations), adequate (within
recommended range) or excessive (.upper cut-off of
recommendations). See Appendix A for an example of this
calculation.
Maternal race/ethnicity was self-reported. We classified
women as having severe nausea and vomiting since the
previous blood draw if it was documented in the medical
record or cited as a reason for hospitalisation. Smoking
status was self-reported at the first prenatal visit and at the
postpartum return visit. We classified route of delivery as
vaginal or abdominal. High birth weight was defined as
birth weight .4000 g. Postpartum haemorrhage was
based on the physician’s subjective opinion documented
in the medical record. Breast-feeding initiation was
classified as ever initiated or never initiated. Breast-
feeding status at the postpartum visit was defined as
exclusively breast-feeding, exclusively formula feeding or
combination feeding.
Statistical analysis
Initially, we screened a large set of variables with potential
relevance to Hb concentration using bivariate linear
regression analysis. Variables with a moderately low
P-value (P , 0.25) were considered further in multi-
variable analysis. Some of these potential predictors of Hb
concentration applied to all time periods (time-indepen-
dent), while others were exclusive to pregnancy or
postpartum. Time-independent factors that met the
aforementioned criterion were ethnicity/race, marital
status, education, parity, height and pre-pregnancy BMI.
Pregnancy factors that met this criterion were GA at
current blood draw, Hb concentration at the previous
blood draw, number of weeks since previous Hb
measurement, SF concentration at the previous blood
draw, smoking status, iron supplement use, pre-eclamp-
sia, severe nausea and vomiting, and adequacy of
gestational weight gain. Postpartum factors that met the
aforementioned criterion were number of weeks post-
partum at current blood draw, Hb concentration at the
previous blood draw, route of delivery, high birth weight,
postpartum haemorrhage, breast-feeding initiation, and
breast-feeding status at the postpartum visit.
To examine the longitudinal pattern of Hb concen-
tration, we plotted pregnancy Hb concentrations by GA
and plotted postpartum Hb concentrations by the number
of weeks since delivery. After testing several transform-
ations of GA in the model, we found the best fit with a
continuous variable. Postpartum Hb concentration
decreased from Week 4 to Week 6.5, and then appeared
to level off. Thus, we used a linear spline with a knot at
6.5 weeks to capture this non-linear relationship.
We fit a longitudinal, multivariable fixed-effects model
predicting Hb concentration from 24 weeks’ gestation
until delivery and from 4 to 25 weeks postpartum. We
chose a fixed-effects regression model because we were
interested in population averages rather than subject-
specific parameters. All aforementioned predictors that
met our a priori criteria were included in the full model.
To build the longitudinal model, we used both PROC
GENMOD and PROC MIXED in SAS software (SAS
Institute, Cary, NC, USA). GENMOD uses generalised
estimating equations, which account for intra-individual
correlation of Hb measurements19. Because results from
both procedures were similar, we used GENMOD to fit the
final model. The longitudinal model accommodated
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women without complete data at all three visits. Akaike’s
Information Criterion20 was used to test several different
covariance structures. We observed the best fit with the
exchangeable covariance structure, so we used it for all
models. The full model was reduced using backward
deletion (P # 0.15). Our final model is shown in Appendix
B. The parameterisation we used allows us to predict Hb
concentration during two different time periods, 24 weeks’
gestation to delivery and 4 to 25 weeks postpartum, with
the constraint that the intercept and the estimates for the
time-independent parameters are the same for both time
periods. This constraint was important because it allows
the effect of the Hb measurements during pregnancy and
postpartum periods to be estimated relative to the same
pre-pregnancy Hb level. Hence, results from our model
will be more easily implemented from a clinician’s
perspective. For clarity we present the modelling results
in two tables (pregnancy and postpartum predictors) even
though they were ultimately derived from the same model.
The distribution of residuals for delivery and post-
partum visits was not normal. After excluding five outliers,
however, normality at all visits was demonstrated. As this
exclusion had minimal influence on the final parameter
estimates (,10% change), we included the outliers in the
results presented here.
We explored non-linear relationships with splines and
other transformations of the predictor variables. For
categorical variables, adjacent categories were grouped if
parameter estimates were similar. We also considered
interactions with time by comparing parameter estimates
in cross-sectional bivariate regressions. Interaction terms
were maintained in the multivariable model if they had
meaningfully different point estimates across strata of
time.
SAS software was used for all data analysis.
Results
Maternal characteristics, including sociodemographic
factors, health habits, pregnancy and delivery compli-
cations, and mean Hb concentrations, are shown in Table 1
for all women in the final analysis. Some totals do not
equal 520 in Table 1 since women only needed to have
complete data for at least one of the three visits to
contribute information to the longitudinal model. Most of
the sample was 20 to 30 years of age, non-Hispanic black,
multiparous and had ,12 years of education.
The final predictive model (Appendix B) was developed
using 520 women who contributed 1112 measurements of
Hb (460 from the third trimester, 299 at delivery, 353 at the
postpartum visit). As stated above, data in Tables 2 and 3
were derived from the same final model but are presented
separately for clarity. Timing of previous Hb measurement
predicted Hb concentrations at 24 to 29 weeks’ gestation
(Table 2). When holding previous Hb concentration
constant, the number of weeks since the previous
measurement was inversely associated with Hb concen-
tration at 24 to 29 weeks. We observed an approximately
linear relationship between Hb concentration and GA
from 24 weeks until delivery, resulting in an increase of
0.26 g l21 in Hb concentration with each increasing week.
Cumulative iron intake through the previous Hb
measurement was positively predictive of current Hb
concentration; whereas, from the previous measurement
to the current measurement, only women who took the
prescribed amount of iron had higher concentrations than
women who took no iron. Severe nausea and vomiting
and inadequate gestational weight gain were negative
predictors of Hb concentration from 24 weeks’ gestation
until delivery.
Hb concentration decreased by 4.08 g l21 per week from
4 to 6.5 weeks postpartum but decreased only slightly with
each week after 6.5 weeks (Table 3). Postpartum
haemorrhage and high infant birth weight were indepen-
dent predictors of reduced Hb concentrations. Eliminating
BMI from the final model had the effect of making the
coefficients for high birth weight (26.52; 95% confidence
interval (CI) 211.6, 21.43; P ¼ 0.01) and postpartum
haemorrhage (26.89; 95% CI 214.3, 0.32; P ¼ 0.06)
stronger and more negative. When abdominal delivery
was included in this model without BMI, it was negatively
associated with postpartum Hb (23.03; 95% CI 26.68,
0.63; P ¼ 0.10).
The effect of BMI on Hb concentration varied by the
time period of interest. During pregnancy, BMI had a slight
positive relationship with Hb concentration, whereas
during the postpartum period, there was a strong inverse
relationship between BMI and Hb concentration (Tables 2
and 3). Regardless of the time of Hb measurement, Hb
concentration at the previous blood draw had a strong,
positive, linear relationship with current Hb concentration,
such that each increase of 1 g l21 in prior Hb resulted in an
increase of 0.59 g l21 in current Hb. Maternal height was a
negative predictor of Hb values. Non-Hispanic white
ethnicity/race, smoking and .12 years of education were
positive predictors of Hb.
Table 4 shows predicted Hb concentrations at 28 weeks
of gestation according to initial Hb, nausea/vomiting
status, adequacy of weight gain and supplement use.
Compared with women with Hb ¼ 125 g l21 at enrolment,
borderline anaemic women (Hb ¼ 110 g l21) at enrolment
had a substantially reduced Hb concentration at 28 weeks’
gestation. Severe nausea and vomiting, inadequate weight
gain and no iron supplement use since enrolment were
predictive of Hb decreases similar in magnitude. Hb
concentrations at 28 weeks were on average 15 g l21
lower in borderline anaemic women who did not use iron
and had both inadequate weight gain and severe
nausea/vomiting, compared with women who used
roughly 30 mg iron per day, had Hb of 125 g l21 at the
initial visit, adequate weight gain and no severe
nausea/vomiting.
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Table 1 Characteristics of the 520 women who contributed data to the longitudinal model*
Characteristic n % or mean (SD)
Age
, 20 years 150 29.0
20–30 years 307 59.4
. 30 years 60 11.6
Ethnicity/race
Non-Hispanic white 160 31.0






# 12 years 416 79.9





, 19.8 kg m22 (underweight) 86 16.5
19.8 to 25.9 kg m22 (normal weight) 228 43.9
26.0 to 29.0 kg m22 (overweight) 61 11.7
. 29.0 kg m22 (obese) 145 27.9
GA at prenatal care initiation (weeks) 520 12.0 (3.4)
Hb concentration at initial visit (g l21) 520 123 (8.8)
SF concentration at initial visit (mg l21) 520 52.3 (44.8)
Smoking status at the initial visit
Smoker 160 31.0
Non-smoker 357 69.0
Severe nausea and vomiting prior to the 24- to 29-week blood draw
Yes 101 21.4
No 370 78.6
Hb concentration at 24–29 weeks’ gestation (g l21) 506 113 (9.2)
GA at 24- to 29-week blood draw (weeks) 506 28.6 (2.0)
SF concentration at 24–29 weeks’ gestation (mg l21) 368 15.5 (13.6)
Severe nausea and vomiting between 24- to 29-week blood draw and delivery
Yes 62 13.2
No 409 86.8
Inadequate gestational weight gain before delivery
Yes 145 28.1
No 372 71.9
Estimated cumulative iron intake from supplements from 24 to 29 weeks of gestation until delivery
0 g 76 15.2
0.1–1.9 g 196 39.1
2.0–3.0 g 155 30.9




Hb concentration before delivery (g l21) 461 117 (10.4)





# 4000 g 477 92.8
. 4000 g 37 7.2
Presence of postpartum haemorrhage
Yes 18 3.5
No 496 96.5
Smoking status at the postpartum visit to the clinic
Smoker 130 25.2
Non-smoker 387 74.9
Hb concentration at the postpartum visit to the clinic (g l21) 399 130 (13.1)




Infant feeding method at the postpartum visit to the clinic
Exclusively breast-feeding 64 16.5
Exclusively formula feeding 253 65.2
Combination feeding 71 18.3
SD – standard deviation; BMI – body mass index; GA – gestational age; Hb – haemoglobin; SF – serum ferritin.
* Some totals will not equal 520 due to missing data on some variables.
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Table 5 shows predicted Hb concentrations at 8 weeks
postpartum by race, haemorrhage, infant birth weight and
pre-pregnancy BMI. High birth weight, postpartum
haemorrhage and a BMI increase of 15 kg m22 had
negative impacts on postpartum Hb concentration similar
in magnitude, whereas ethnicity/race had a relatively small
influence on Hb values. A pre-pregnancy BMI of
36 kg m22 predicted a Hb concentration that indicated
anaemia or borderline anaemia at 8 weeks postpartum
when the delivery was complicated by either high infant





Number of weeks since previous Hb measurement‡ 20.38 (20.52, 20.24) ,0.001
GA (weeks) 0.26 (0.05, 0.47) 0.01
Estimated cumulative iron intake from supplements to the previous Hb measurement§
. 0 g, ,prescribed{ (vs. 0 g) 1.78 (20.67, 4.22) 0.21
Prescribed (vs. 0 g) 2.90 (0.29, 5.50) 0.05
. Prescribed (vs. 0 g) 3.59 (0.01, 7.16) 0.07
Estimated cumulative iron intake from supplements from the previous Hb measurement to the current Hb measurement
. 0 g, ,prescribed{ (vs. 0 g) 0.02 (21.70, 1.74) 0.98
Prescribed (vs. 0 g) 1.94 (0.26, 3.62) 0.05
. Prescribed (vs. 0 g) 0.46 (21.93, 2.84) 0.72
Severe nausea and vomiting from the previous Hb measurement to the
current Hb measurement (vs. none)
21.80 (23.31, 20.30) 0.01
Inadequate gestational weight gain to the current Hb measurement (vs. other) 22.02 (23.28, 20.76) 0.002
Constrained time-independent variablesk
Pre-pregnancy BMI (kg m22) 0.07 (20.01, 0.15) 0.08
Hb concentration (g l21) at the previous blood draw 0.59 (0.52, 0.67) ,0.001
Maternal height (cm) 20.05 (20.11, 0.01) 0.09
Non-Hispanic white (vs.other) 1.12 (20.03, 2.28) 0.05
.12 years of education (vs. #12 years) 1.18 (20.07, 2.43) 0.06
Smoker (vs. non-smoker) 1.38 (0.18, 2.57) 0.02
Intercept 45.5 (30.5, 60.3) ,0.001
Hb – haemoglobin; CI – confidence interval; GA – gestational age; BMI – body mass index.
* Based on a fixed-effects longitudinal model (Appendix B).
† Unless otherwise indicated, each coefficient represents the change in Hb concentration (g l21) for a one-unit increase in the x variable.
‡ Only applicable to second blood draw at 24 to 29 weeks’ gestation.
§ Only applicable to the delivery blood draw.
{From the start of prenatal care until 24–29 weeks’ gestation: 0.1–1.9 g (,prescribed), 2.0–3.5 g (prescribed), .3.5 g (.prescribed). From 24–29 weeks’
gestation until delivery: 0.1–1.9 g (,prescribed), 2.0–3.0 g (prescribed), .3.0 g (.prescribed).
kTime-independent parameters are constrained to be the same estimates for both pregnancy and postpartum time periods by the longitudinal model
(Appendix B).






4 to 25 weeks postpartum‡ (vs. pregnant) 60.0 (35.8, 84.1) ,0.001
Number of weeks since delivery, if #6.5 weeks 24.08 (27.67, 20.48) 0.02
Number of weeks since delivery, if .6.5 weeks 20.43 (20.90, 0.38) 0.07
Postpartum haemorrhage (vs. no haemorrhage) 26.40 (213.3, 0.47) 0.06
Infant birth weight .4000 g (vs. #4000 g) 25.17 (210.1, 20.28) 0.03
Interaction: [Pre-pregnancy BMI (kg m22)] £ (4–25 weeks postpartum‡) 20.45 (20.65, 20.26) ,0.001
Constrained time-independent variables§
Pre-pregnancy BMI (kg m22) 0.07 (20.01, 0.15) 0.08
Hb concentration (g l21) at the previous blood draw 0.59 (0.52, 0.67) ,0.001
Maternal height (cm) 20.05 (20.11, 0.01) 0.09
Non-Hispanic white (vs. other) 1.12 (20.03, 2.28) 0.05
.12 years of education (vs. #12 years) 1.18 (20.07, 2.43) 0.06
Smoker (vs. non-smoker) 1.38 (0.18, 2.57) 0.02
Intercept 45.5 (30.5, 60.3) ,0.001
Hb – haemoglobin; CI – confidence interval; BMI – body mass index.
* Based on a fixed-effects longitudinal model (Appendix B).
† Unless otherwise indicated, each coefficient represents the change in Hb concentration (g l21) for a one-unit increase in the x
variable.
‡ Coded as yes or no.
§ Time-independent parameters are constrained to be the same estimates for both pregnancy and postpartum time periods by
the longitudinal model (Appendix B).
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birth weight or haemorrhage. Similarly, Hb concentrations
indicating anaemia were predicted when both high infant
birth weight and postpartum haemorrhage occurred in a
woman with a BMI of 28 kg m22, regardless of race.
Discussion
Among women of childbearing age in the USA, iron status
is recognised as the most important biological determinant
of Hb concentration8. Poor iron status is associated with
adverse functional consequences, so understanding the
predictors of iron status is of great public health
importance. Despite the plethora of publications on
haemoglobin concentration, a Medline search using the
key words ‘hemoglobin’ and ‘pregnancy’ or ‘puerperium’
suggests that this may be the first multivariable analysis of
a wide selection of clinically relevant predictors of Hb
concentration during and after pregnancy conducted in a
non-malarial region.
We observed an inverse relationship between Hb
concentration and both severe nausea and vomiting and
inadequate weight gain – two conditions associated with
inadequate intake of many nutrients, including iron.
Interestingly, these factors’ relationships with Hb concen-
tration or other iron status measures have not been studied
previously.
Postpartum haemorrhage and high infant birth weight
(macrosomia) were strong, negative predictors of post-
partum Hb concentration. Women who have a clinically
recognised haemorrhage may lose up to 1000 ml of
blood21 (the equivalent of 400 mg of iron22), which may
impede the recovery of Hb concentration in the
postpartum period. We lacked estimates of total blood
loss, thus we could not evaluate how well blood loss, per
se, predicts postpartum Hb concentration. Macrosomia can
cause significant blood loss via a number of adverse
maternal outcomes: abdominal delivery23, operative
vaginal delivery24,25 and perineal rupture and haemor-
rhage26. Macrosomia also lengthens duration of lochia, the
vaginal discharge of blood following childbirth27, which
may adversely affect postpartum iron status28. Pre-
pregnancy overweight is a risk factor for macrosomia29,
but in our data macrosomia predicted Hb concentrations
independent of BMI.
Pre-pregnancy BMI was a modest positive predictor of
pregnancy Hb concentration, but was a strong negative
Table 4 Predicted Hb concentration* at 28 weeks of gestation by Hb concentration at the initial visit, adequacy of gestational weight gain







0 g cumulative supplement
use from the initial visit
to 28 weeks’ gestation
2.0–3.0 g cumulative supplement
use from the initial visit
to 28 weeks’ gestation
125 Adequate No 114 (112, 116) 116 (114, 118)
Yes 112 (110, 115) 114 (112, 116)
Inadequate No 112 (110, 114) 114 (112, 116)
Yes 110 (108, 113) 112 (110, 115)
110 Adequate No 105 (103, 107) 107 (105, 109)
Yes 103 (101, 106) 105 (103, 108)
Inadequate No 103 (101, 106) 105 (103, 107)
Yes 101 (99, 104) 103 (101, 106)
Hb – haemoglobin; BMI – body mass index; CI – confidence interval.
* Values are expressed as Hb concentration in g l21 (95% CI).
† Other variables held constant: initial visit at 12 weeks’ gestation, non-Hispanic white ethnicity/race, 12 years of education or less, non-smoker,
height ¼ 163 cm (64 in), and pre-pregnancy BMI ¼ 24 kg m22.
‡ Predicted values are based on the final model shown in Table 2 and Appendix B.
Table 5 Predicted Hb concentration* at 8 weeks’ postpartum by race, infant birth weight, postpartum
haemorrhage, and pre-pregnancy BMI†‡
Race
Infant birth
weight . 4000 g
Postpartum
haemorrhage BMI ¼ 21 kg m22 BMI ¼ 28 kg m22 BMI ¼ 36 kg m22
White No No 131 (130, 133) 129 (127, 130) 126 (123, 128)
Yes 125 (120, 129) 122 (118, 127) 119 (115, 124)
Yes No 126 (122, 130) 123 (119, 127) 120 (116, 124)
Yes 120 (114, 125) 117 (111, 123) 114 (108, 120)
Non-white No No 130 (129, 132) 127 (126, 129) 124 (123, 126)
Yes 124 (119, 128) 121 (117, 125) 118 (114, 123)
Yes No 125 (121, 129) 122 (118, 126) 119 (115, 123)
Yes 119 (113, 124) 116 (110, 121) 112 (107, 118)
Hb – haemoglobin; BMI – body mass index; CI – confidence interval.
* Values are expressed as Hb concentration in g l21 (95% CI).
† Other variables held constant: 117 g l21 Hb concentration before delivery, 12 years of education or less, non-smoker,
and height ¼ 163 cm (64 in).
‡ Predicted values are based on the final model shown in Table 3 and Appendix B.
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predictor of postpartum Hb; a 15 kg m22 increase in BMI
was associated with a 5.7 g l21 decrease in postpartum Hb.
BMI is most likely a marker of blood loss at delivery.
Obesity is a well-documented risk factor for postpartum
haemorrhage30 and abdominal delivery31. In our model,
pre-pregnancy BMI and haemorrhage were independent
predictors of postpartum Hb concentration. Therefore, in
our model BMI may account for the residual effect of
blood loss on Hb concentration that is not specifically
captured by haemorrhage, a dichotomous variable.
Estimated cumulative supplemental iron intake through
the previous blood draw positively predicted Hb
concentrations. However, only estimated intakes roughly
equivalent to the prescribed amount from the previous
blood draw to the current measurement were predictive of
higher Hb levels than receiving no supplemental iron. Our
methods of estimating iron supplement use were
imperfect, however, because our study was not originally
designed to collect such data after 24 weeks’ gestation.
We observed a longitudinal pattern of Hb concentration
during pregnancy that has been well documented. The
number of weeks since the initial prenatal visit had a
strong inverse relationship with Hb concentration at the
24- to 29-week blood draw, reflecting a decreasing Hb
concentration through roughly the first two trimesters that
results from plasma volume expansion and haemodilu-
tion9. Hb concentration increased from 24 weeks to
delivery, marking the increased rate of red cell mass
expansion9,10.
From 4 to 25 weeks postpartum, our data showed a
downward trend in Hb concentration that was most
pronounced from 4 to 6.5 weeks postpartum and was
evident even after controlling for several factors suspected
to influence Hb values. Randomised controlled trials that
followed women after delivery have shown Hb levels to
increase sharply from 1 week to 8 weeks postpartum, then
either remain constant or increase to 25 weeks post-
partum32–35. Our contrary findings are probably due to
differences in menstruation status, which we did not
measure. Prevalence of amenorrhoea decreases as time
postpartum increases36. Themajority of our samplewas not
lactating, and at 6 and 12 weeks postpartum, 40 and 65%,
respectively, of non-lactating women return to menses36.
Menstruation increases iron needs by 0.5 mg day21 if
averaged over the course of the month37, so Hb
concentration may be depressed when menses resume if
requirements are not being met by intake or iron stores.
The limitations of this study deserve attention. Missing
data were a problem, but the loss to follow-up we
experienced is not unlike real-life circumstances of
women receiving care in public health clinics. In our
low-income population, women missed appointments,
transferred to other clinics, delivered at alternative
hospitals, and/or did not return for postpartum care.
None the less, the characteristics of the women contribut-
ing complete information to the longitudinal model for all
three visits were similar to those contributing data for one
visit. Additionally, the 520 women used for this analysis
were similar to the 867 women randomised. This suggests
that the results may have good generalisability to the
cohort.
Furthermore, we obtained similar parameter estimates
when our model was run using two SAS procedures with
different assumptions about missing data. The assumption
underlying the results obtained from PROC GENMOD is
that the outcome data are a random sub-sample of the
target population (the data are missing completely at
random), whereas results from PROC MIXED assume that
the observed data explain the missing outcome data (the
data are missing at random)38. The fact that results were
similar when the model was run using both procedures
supports the missing completely at random assumption for
our data. These findings suggest that selection bias was
unlikely to be a major concern in this analysis.
The Iron Supplementation Study was not designed with
these analyses in mind. Therefore, misclassification may
have been a problem in our analysis, specifically for iron
exposure during pregnancy, which was found to be only a
moderate predictor of Hb concentration. We estimated
iron intake based on the relationship between pill counts
from enrolment to 24–29 weeks and pharmacy data from
enrolment to 24–29 weeks in a small sample of women
who returned pill bottles, who may not be a representative
group. Furthermore, pill-count data were based on pills
containing up to 60 g of iron from the start of care to 24–29
weeks, whereas beyond 24–29 weeks, women in some
cases were prescribed substantially higher doses. Our
analysis assumed that the association between pill-count
and pharmacy data was the same regardless of dose,
which may not be the case. These factors probably
underestimated the true magnitude with which iron
exposure predicts Hb concentration.
In addition, since the Iron Supplementation Study was
not designed to follow women into the postpartum
period, we were missing several postpartum variables,
including dietary intake, iron supplement use and blood
loss. Other studies should collect such data to determine
whether the postpartum predictors we have identified
remain important throughout the postpartum period, once
these other variables are accounted for.
Our study had adequate power to detect relatively small
differences in Hb concentration for each predictor
variable. Specifically, we had 80% power to detect a
1.5 g l21 difference in Hb concentration, assuming
a ¼ 0.05 and standard deviation of 13 g l21. This sample
size, however, was not large enough to develop the
predictive model in one half and test its validity in the
other half. Therefore, we encourage others to apply our
predictive model to other populations to confirm or refute
our results.
Our analysis demonstrated that, apart from the blood
volume changes that accompany normal pregnancy, a
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number of other factors predict gestational and post-
partum Hb concentrations in our population. While these
factors appear to be consistent with scientific knowledge,
the current recommendations for preventing iron
deficiency in pregnant and postpartum women do not
make mention of many of the factors we have identified as
putting women at high risk of adverse iron status14.
Therefore, poor iron status among pregnant women who
have inadequate weight gain or severe nausea and
vomiting, for instance, may go unnoticed. In addition,
women with a high pre-pregnancy BMI or a high-birth-
weight infant would not be screened in the postpartum
period according to the present policies. These data
suggest that more attention should be paid to maternal
factors and complications of pregnancy and delivery as
risk markers of poor iron status. The results also highlight
the importance of improving existing policies and
developing new policies to ensure adherence to iron
supplements during pregnancy. Iron supplement use in
the postpartum period also deserves more attention, as
our knowledge on this subject is currently limited.
Predictors of iron status that we have identified here
should be tested in other populations. If our findings are
replicated in other settings, the factors we have identified
as predictors could be used in clinics to identify high-risk
women who should be targeted for intervention. Such
interventions would include counselling women with
inadequate gestational weight gain on ways to improve
iron and overall dietary intake. In addition to checking
iron status frequently in these women, iron status among
women with severe nausea and vomiting should also be
carefully monitored, particularly if the nausea and
vomiting inhibit adequate iron intake via diet and
supplements. Iron supplementation after delivery may
be beneficial to overweight women, women with a
macrosomic infant or women who had a haemorrhage.
Furthermore, postpartum anaemia screening for iron
deficiency in these high-risk groups may be warranted.
Such intervention strategies might prove useful in
improving iron status, thereby preventing adverse func-
tional outcomes of iron deficiency among pregnant and
postpartum women.
Acknowledgements
This research was funded by co-operative agreements
from the Association of Schools of Public Health/Centers
for Disease Control and Prevention (#S1326 and #S0454), a
predoctoral traineeship from the National Institutes of
Health and a Woodrow-Wilson Johnson & Johnson
dissertation grant in women’s health, and was supported
by the Carolina Population Center. We thank Dr Mary E
Cogswell and Dr Linda S Adair for providing insightful
comments. We gratefully acknowledge the prenatal clinic
staff of Wake County Human Services, and thank Mead-
Johnson Pharmaceuticals for providing iron supplements.
References
1 Bodnar LM, Scanlon KS, Freedman DS, Siega-Riz AM,
Cogswell ME. High prevalence of postpartum anemia among
low-income women in the United States. American Journal
of Obstetrics and Gynecology 2001; 185: 438–43.
2 Bodnar LM, Cogswell ME, Scanlon KS. Low income
postpartum women are at risk of iron deficiency. Journal
of Nutrition 2002; 132: 2299–303.
3 Centers for Disease Control and Prevention (CDC).
Pregnancy Nutrition Surveillance, 1996 Full Report. Atlanta,
GA: US Department of Health and Human Services, CDC,
1998.
4 Haas JD, Brownlie T. Iron deficiency and reduced work
capacity: a critical review of the research to determine a
causal relationship. Journal of Nutrition 2001; 131:
676S–88S.
5 Bruner AB, Joffe A, Duggan AK, Casella JF, Brandt J.
Randomised study of cognitive effects of iron supplemen-
tation in non-anaemic iron-deficient adolescent girls. Lancet
1996; 348: 992–6.
6 Ballin A, Berar M, Rubinstein U, Kleter Y, Hershkovitz A,
Meytes D. Iron state in female adolescents. American
Journal of Diseases of Children 1992; 146: 803–5.
7 Rasmussen KM. Is there a causal relationship between iron
deficiency or iron-deficiency anemia and weight at birth,
length of gestation, and perinatal mortality? Journal of
Nutrition 2001; 131: 590S–601S.
8 Yip R, Dallman PR. The roles of inflammation and iron
deficiency as causes of anemia. American Journal of
Clinical Nutrition 1988; 48: 1295–300.
9 Institute of Medicine, Food and Nutrition Board. Nutrition
during Pregnancy. Washington, DC: National Academy
Press, 1990.
10 Taylor DJ, Lind T. Red cell mass during and after normal
pregnancy. British Journal of Obstetrics and Gynaecology
1979; 86: 364–70.
11 Blackburn ST, Loper DL. Maternal, Fetal, and Neonatal
Physiology: A Clinical Perspective. Philadelphia, PA: WB
Saunders, 1992.
12 Friis H, Gomo E, Kæstel P, Ndhlovu P, Nyazema N, Krarup H,
et al. HIVand other predictors of serum folate, serum ferritin,
and hemoglobin in pregnancy: a cross-sectional study in
Zimbabwe. American Journal of Clinical Nutrition 2001; 73:
1066–73.
13 Robinson S, Godfrey K, Denne J, Cox V. The determinants of
iron status in early pregnancy. British Journal of Nutrition
1998; 79: 249–55.
14 Centers for Disease Control and Prevention. Recommen-
dations to prevent and control iron deficiency in the United
States. Morbidity and Mortality Weekly Report 1998; 47(RR-3).
15 US Department of Health and Human Services Resources.
Healthy People 2010: National Health Promotion and
Disease Prevention Objectives, [online]. Available at http://
www.health.gov/healthypeople/Publications/. Accessed 21
January 2003.
16 Siega-Riz AM, Hartzema A, Thorp J, McDonald T, Turnbull C,
Cogswell ME. Selective versus universal iron supplemen-
tation during pregnancy: prevention of third-trimester
anemia. FASEB Journal 2001; 15: A974.
17 Bodnar LM, Davidian M, Siega-Riz AM, Tsiatis AA.
Marginal structural models for analyzing causal effects of
time-dependent treatments: an application in perinatal
epidemiology. American Journal of Epidemiology 2004;
in press.
18 Siega-Riz AM, Adair LS, Hobel CJ. Maternal underweight
status and inadequate rate of weight gain during the third
trimester of pregnancy increases the risk of preterm delivery.
Journal of Nutrition 1996; 126: 146–53.
Predictors of haemoglobin concentration 709
Downloaded from https://www.cambridge.org/core. 05 Feb 2021 at 14:10:59, subject to the Cambridge Core terms of use.
19 Zeger SL, Liang KY. Longitudinal data analysis for discrete
and continuous outcomes. Biometrics 1986; 42: 121–30.
20 Akaike H. Likelihood of model and information criteria.
Journal of Econometrics 1981; 16: 3–14.
21 American College of Obstetricians and Gynecologists.
Postpartum hemorrhage [ACOG Educational Bulletin, No.
243, January 1998]. International Journal of Gynaecology
and Obstetrics 1998; 61: 79–86.
22 Bothwell TH, Charlton RW, Cook JD, Finch CA. Iron
Metabolism in Man. Oxford: Blackwell Scientific Publi-
cations, 1979; 576.
23 Spellacy WN, Miller S, Winegar A, Peterson PQ. Macrosomia
– maternal characteristics and infant complications. Obste-
trics and Gynecology 1985; 66: 158–61.
24 Zetterstrom J, Lopez A, Anzen B, Norman M, Holstrom B,
Mellgren A. Anal sphincter tears at vaginal delivery: risk
factors and clinical outcome of primary repair. Obstetrics
and Gynecology 1999; 94: 21–8.
25 Turner MJ, Rasmussen MJ, Turner ME, Boylan PC,
MacDonald D, Stronge JM. The influence of birth weight
on labour in nulliparas. Obstetrics and Gynecology 1990; 76:
79–83.
26 Axelsson O. Delivery of the large fetus. Acta Obstetricia et
Gynecologica Scandinavica 1990; 69: 473–4.
27 Oppenheimer LW, Sherriff EA, Goodman JD, Shah D, James
CE. The duration of lochia. British Journal of Obstetrics and
Gynaecology 1986; 93: 754–7.
28 Paterson JA, Davis J, Gregory M, Holt SJR, Pachulski A,
Stamford DE, et al. A study on the effects of low
haemoglobin on postnatal women. Midwifery 1994; 10:
77–86.
29 Larsen CE, Serdula MK, Sullivan KM. Macrosomia: influence
of maternal overweight among a low-income population.
American Journal of Obstetrics and Gynecology 1990; 162:
490–4.
30 Combs CA, Murphy EL, Laros RK. Factors associated with
postpartum hemorrhage with vaginal birth. Obstetrics and
Gynecology 1991; 77: 69–76.
31 Crane SS, Wojtowycz MA, Dye TD, Aubry RH, Artal R.
Association between prepregnancy obesity and risk of
cesarean delivery. Obstetrics and Gynecology 1997; 89:
213–6.
32 Taylor DJ, Mallen C, McDougall N, Lind T. Effect of iron
supplementation on serum ferritin levels during and after
pregnancy. British Journal of Obstetrics and Gynaecology
1982; 89: 1010–7.
33 Milman N, Agger AO, Nielsen OJ. Iron supplementation
during pregnancy. Effect on iron status markers, serum
erythropoietin and human placental lactogen. A placebo
controlled study in 207 Danish women. Danish Medical
Bulletin 1991; 38: 471–6.
34 Eskeland B, Malterud K, Ulvik RJ, Hunskaar S. Iron
supplementation in pregnancy: is less enough? A random-
ized, placebo controlled trial of low dose iron supplemen-
tation with and without heme iron. Acta Obstetricia et
Gynecologica Scandinavica 1997; 76: 822–8.
35 Preziosi P, Prual A, Galan P, Daouda H, Boureima H,
Hercberg S. Effect of iron supplementation on the iron status
of pregnant women: consequences for newborns. American
Journal of Clinical Nutrition 1997; 66: 1178–82.
36 Collins JB. Puerperium. Primary Care 1983; 10: 309–32.
37 Bothwell TH, Charlton RW. Iron Deficiency in
Women. Report of the International Nutritional Anemia
Consultative Group. Washington, DC: The Nutrition
Foundation, 1981.
38 SAS Institute. SAS STAT. Cary, NC: SAS Institute, 2000.
Appendix A
Example of the adequacy of weight gain calculation
for normal pre-pregnancy BMI
The Institute of Medicine9 recommends a weight-gain rate
of 2.2 kg in the first trimester and 0.4 kg week21 in the
second and third trimesters. Therefore, expected gesta-
tional weight gain at 40 weeks’ gestation is:
2:2 kgþ ½ð40 weeks 2 13 weeksÞ £ 0:4 kg week21
¼ 13 kg:
The Institute of Medicine recommends a total weight-gain
range of 11.5–16 kg, which corresponds to 88–123% of
the 13-kg expected weight gain (i.e.
(11.5 kg/13 kg) £ 100 ¼ 88%). We classified inadequate,
adequate and excessive weight gain as ,88%, 88–123%
and .123% of recommendations, respectively.
Example for a normal-weight woman who gained a
total of 18 kg and whose weight was last measured
at 38 weeks’ gestation
Expected gestational weight gain
¼ 2:2 kgþ ½ð38 weeks 2 13 weeksÞ £ 0:4 kg week21
¼ 12:2 kg:
Percentage of recommendations met
¼ ð18 kg=12:2 kgÞ £ 100 ¼ 148%:
148% is greater than 123%, so this woman is classified as
exhibiting excessive weight gain.
Appendix B
























t ¼ 1 if 24 # weeks’ gestation # 42
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t ¼ 2 if 4 # week postpartum # 25.
x1w ¼ Hb concentration (g l
21) at the previous blood
draw
x2w ¼ maternal height (cm)
x3w ¼ pre-pregnancy BMI (kg m
22)
x4w ¼ pre-pregnancy BMI (kg m
22) £ (4–25 weeks
postpartum)
x5w ¼ non-Hispanic white (vs. other)
x6w ¼ more than 12 years of education (vs. #12
years)
x7w ¼ smoker (vs. non-smoker).
yjwt ¼ 0 if t ¼ 2; otherwise
y1w ¼ number of weeks since previous Hb
measurement
y2w ¼ gestational age (weeks)
y3w ¼ cumulative iron intake to the previous Hb
measurement: .0 g, ,prescribed (vs. 0 g)
y4w ¼ cumulative iron intake to the previous Hb
measurement: prescribed (vs. 0 g)
y5w ¼ cumulative iron intake to the previous Hb
measurement: .prescribed (vs. 0 g)
y6w ¼ cumulative iron intake from the previous Hb
measurement to the current: .0 g, ,prescribed (vs. 0 g)
y7w ¼ cumulative iron intake from the previous Hb
measurement to the current: prescribed (vs. 0 g)
y8w ¼ cumulative iron intake from the previous Hb
measurement to the current: .prescribed (vs. 0 g)
y9w ¼ severe nausea and vomiting from the previous
Hb measurement to the current (vs. none)
y10w ¼ inadequate gestational weight gain to the
current Hb measurement (vs. other).
zkwt ¼ 0 if t ¼ 1; otherwise
z1w ¼ 4 to 25 weeks postpartum (vs. pregnant)
z2w ¼ number of weeks since delivery
z3w ¼ number of weeks since delivery minus 6.5, if
weeks postpartum .6.5*
z4w ¼ postpartum haemorrhage
z5w ¼ infant birth weight .4000 g.
*In Table 2, the coefficient for ‘Number of weeks since delivery, if
.6.5 weeks’ represents a linear combination of the parameter
estimates of z2w and z3w.
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